Perspectives on electrochemical biosensing of COVID-19

© 2021 Elsevier B.V. All rights reserved..

Rapid detection of human coronavirus disease 2019, termed as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or COVID-19 infection, is urgently needed for containment strategy owing to its unprecedented spreading. Novel biosensors can be deployed in remote clinical settings without central facilities for infection screening. Electrochemical biosensors serve as analytical tools for rapid detection of viral structure proteins, mainly spike (S) and nucleocapsid (N) proteins, human immune responses, reactive oxygen species, viral ribonucleic acid, polymerase chain reaction by-products, and other potential biomarkers. The development of point-of-care testing devices is challenging due to the requirement of extensive validation, a time-consuming and expensive step. Together with specific biorecognition molecules, nanomaterial-based biosensors have emerged for the fast detection of early viral infections.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:30

Enthalten in:

Current opinion in electrochemistry - 30(2021) vom: 30. Dez., Seite 100794

Sprache:

Englisch

Beteiligte Personen:

Luong, Albert D [VerfasserIn]
Buzid, Alyah [VerfasserIn]
Vashist, Sandeep K [VerfasserIn]
Luong, John H T [VerfasserIn]

Links:

Volltext

Themen:

Antibodies
Biosensor
Diagnosis
Electrochemistry
Journal Article
Point of care
Review
SARS-CoV-2
Viral proteins

Anmerkungen:

Date Revised 30.11.2022

published: Print-Electronic

Citation Status PubMed-not-MEDLINE

doi:

10.1016/j.coelec.2021.100794

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM327961368